Value8 N.V (PREVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Value8 N.V (PREVA) has a cash flow conversion efficiency ratio of 0.000x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€23.00K ≈ $26.89K USD) by net assets (€121.23 Million ≈ $141.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Value8 N.V market capitalisation for the company's overall valuation and market capitalisation.
Value8 N.V - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Value8 N.V's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Value8 N.V Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Value8 N.V ranked by their cash flow conversion efficiency. Explore earnings quality score of Value8 N.V to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Basel Medical Group Ltd Ordinary Shares
NASDAQ:BMGL
|
N/A |
|
Oylum Sinai Yatirimlar AS
IS:OYLUM
|
0.179x |
|
5G Networks Ltd
AU:5GN
|
-0.146x |
|
S F Capital Bhd
KLSE:8745
|
-0.131x |
|
Hancom MDS Inc
KQ:086960
|
0.040x |
|
Fingerprint Cards AB (publ)
ST:FING-B
|
-0.007x |
|
Spring Ventures Ltd
TA:SPRG
|
-0.016x |
|
Putra Rajawali Kencana PT
JK:PURA
|
0.012x |
Annual Cash Flow Conversion Efficiency for Value8 N.V (2004–2025)
The table below shows the annual cash flow conversion efficiency of Value8 N.V from 2004 to 2025. View PREVA stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €119.16 Million ≈ $139.31 Million |
€-904.00K ≈ $-1.06 Million |
-0.008x | -112.27% |
| 2024-12-31 | €103.00 Million ≈ $120.42 Million |
€6.37 Million ≈ $7.45 Million |
0.062x | +567.45% |
| 2023-12-31 | €97.22 Million ≈ $113.66 Million |
€-1.29 Million ≈ $-1.50 Million |
-0.013x | -128.76% |
| 2022-12-31 | €91.90 Million ≈ $107.44 Million |
€4.23 Million ≈ $4.94 Million |
0.046x | +135.85% |
| 2021-12-31 | €96.09 Million ≈ $112.35 Million |
€-12.33 Million ≈ $-14.42 Million |
-0.128x | +33.18% |
| 2020-12-31 | €78.39 Million ≈ $91.64 Million |
€-15.05 Million ≈ $-17.60 Million |
-0.192x | -204.35% |
| 2019-12-31 | €71.33 Million ≈ $83.39 Million |
€13.13 Million ≈ $15.35 Million |
0.184x | -61.25% |
| 2018-12-31 | €72.21 Million ≈ $84.42 Million |
€34.29 Million ≈ $40.09 Million |
0.475x | +692.78% |
| 2017-12-31 | €79.33 Million ≈ $92.74 Million |
€4.75 Million ≈ $5.56 Million |
0.060x | +67.67% |
| 2016-12-31 | €68.99 Million ≈ $80.66 Million |
€2.46 Million ≈ $2.88 Million |
0.036x | -33.51% |
| 2015-12-31 | €61.73 Million ≈ $72.17 Million |
€3.32 Million ≈ $3.88 Million |
0.054x | +560.79% |
| 2014-12-31 | €49.91 Million ≈ $58.35 Million |
€-582.00K ≈ $-680.42K |
-0.012x | -108.26% |
| 2013-12-31 | €37.13 Million ≈ $43.41 Million |
€5.24 Million ≈ $6.13 Million |
0.141x | +324.27% |
| 2012-12-31 | €20.43 Million ≈ $23.88 Million |
€680.00K ≈ $794.99K |
0.033x | +136.29% |
| 2011-12-31 | €17.49 Million ≈ $20.45 Million |
€-1.60 Million ≈ $-1.88 Million |
-0.092x | -1240.09% |
| 2010-12-31 | €11.84 Million ≈ $13.84 Million |
€-81.00K ≈ $-94.70K |
-0.007x | +83.96% |
| 2009-12-31 | €4.71 Million ≈ $5.51 Million |
€-201.00K ≈ $-234.99K |
-0.043x | -104.22% |
| 2008-12-31 | €507.00K ≈ $592.74K |
€513.00K ≈ $599.75K |
1.012x | +971.51% |
| 2007-12-31 | €4.54 Million ≈ $5.31 Million |
€429.00K ≈ $501.55K |
0.094x | -59.45% |
| 2006-12-31 | €4.28 Million ≈ $5.00 Million |
€997.00K ≈ $1.17 Million |
0.233x | -69.73% |
| 2005-12-31 | €2.82 Million ≈ $3.29 Million |
€2.17 Million ≈ $2.53 Million |
0.769x | +177.61% |
| 2004-12-31 | €4.10 Million ≈ $4.79 Million |
€1.14 Million ≈ $1.33 Million |
0.277x | -- |
About Value8 N.V
Value8 N.V. is a private equity firm specializing in middle market, buyout, growth capital investments in small and medium-sized companies. The firm primarily invests in food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium a… Read more